Background Few therapeutic options are available to treat the late-stage of human African
trypanosomiasis, a neglected tropical disease, caused by Trypanosoma brucei gambiense (g-…

Background There is an increased burden of diabetes globally including in sub-Saharan
Africa. The literature shows that glycaemic control among type 2 diabetes patients is poor in …

In Kinshasa, Democratic Republic of the Congo (DRC), between 68–86% of patients with
type 2 diabetes present with poor glycaemic control leading to increased risk of complications …

Background Sleeping sickness (human African trypanosomiasis [HAT]) is a neglected tropical
disease with limited treatment options that currently require parenteral administration. In …

Glycaemic control is a significant problem in the Democratic Republic of the Congo (DRC),
the perspectives associated with glycaemic control are not fully known as previous studies …

Background Fexinidazole has been reported as an effective oral monotherapy against non-severe
gambiense human African trypanosomiasis in a recent trial in adults. We aimed to …

Diabetes is a significant problem in sub-Saharan Africa and achieving glycaemic control
poses a health challenge among patients living with type 2 diabetes. There are limited data on …

Full article: Consensus on potential interventions for improving glycaemic control among
patients with type 2 diabetes in Kinshasa, Democratic Republic of the Congo: a Delphi study …

Background : Hypertension is a serious public health challenge in both economically developing
and developed countries. Patients on outpatient medication for hypertension at Vanga …

Background Sleeping sickness (human African trypanosomiasis [HAT]) is caused by
protozoan parasites and characterized by a chronic progressive course, which may last up to …